-+ 0.00%
-+ 0.00%
-+ 0.00%

Co-Diagnostics Sets 1-for-25 Reverse Stock Split for Nov. 24

PUBT·11/19/2026 22:02:10
Diffusion vocale
Co-Diagnostics Sets 1-for-25 Reverse Stock Split for Nov. 24
  • Co-Diagnostics will implement a 1-for-25 reverse stock split effective at 12:01 a.m. ET on November 24, 2026.
  • Split-adjusted trading begins November 24 on the Nasdaq Capital Market under CODX.
  • The split aims to maintain compliance with Nasdaq's $1 minimum bid price requirement while preserving capacity for equity financing.
  • Outstanding common shares are expected to fall to approximately 521,779 from 13,044,465; authorized shares will remain unchanged.
  • Fractional shares will be rounded up to the next whole share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611191700PR_NEWS_USPR_____LA03079) on November 19, 2026, and is solely responsible for the information contained therein.